Login
$BHC
$8.42 +$0.00 (0.0%) After hours

$BHC 8-K SEC Filings

Filed On Filing
28 Oct 2026 8-K: Results of Operations and Financial Condition

LAVAL, QC, October 28, 2026 – Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ("Bausch Health" or the "Company" or "we" or "our") today announced its third quarter 2026 financial results and other key updates from the quarter.

29 Jul 2026 8-K: Results of Operations and Financial Condition

LAVAL, QC, July 29, 2026 – Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ("Bausch Health" or the "Company" or "we" or "our") today announced its second quarter 2026 financial results and other key updates from the quarter.

01 Jul 2026 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure

LAVAL, Quebec, July 1, 2026 – Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced that Michael Goettler has resigned from its Board of Directors, effective June 30, 2026, in connection with his appointment as President and C...

19 May 2026 8-K: Submission of Matters to a Vote of Security Holders

On May 19, 2026, Bausch Health Companies Inc. (the “Company”) held its Annual Meeting of Shareholders (the “Annual Meeting”). At the Annual Meeting, the shareholders of the Company voted on the following three proposals, each of which is...

29 Apr 2026 8-K: Results of Operations and Financial Condition

LAVAL, QC, April 29, 2026 – Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ("Bausch Health" or the "Company" or "we" or "our") today announced its first quarter 2026 financial results and other key updates from the quarter.

02 Mar 2026 8-K: Departure/Election of Directors or Officers; Compensation

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

18 Feb 2026 8-K: Results of Operations and Financial Condition

LAVAL, QC, February 18, 2026 – Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ("Bausch Health" the "Company," "we" or "our") today announced its fourth quarter and full-year 2025 financial results and other key updates for the quarter.

23 Jan 2026 8-K: Regulation FD Disclosure

[email protected] [email protected]

13 Jan 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

As previously announced through a news wire release on January 5, 2026, Bausch Health Companies Inc. (the “Company” or “Bausch Health”) will participate in the 44th Annual J.P. Morgan Healthcare Conference (the “JPM Conference”) on Janua...

02 Jan 2026 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more

FOURTH AMENDMENT (this “Agreement”), dated as of January 2, 2026, among Bausch + Lomb Corporation, a corporation incorporated under the Canada Business Corporations Act (the “Borrower”), certain subsidiaries of the Borrower, as Subsidiar...

29 Dec 2025 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation

SECOND SUPPLEMENTAL INDENTURE, dated as of December 26, 2025 (this “Second Supplemental Indenture”) by and among 1261229 B.C. Ltd., a corporation incorporated under the laws of the Province of British Columbia (the “Issuer”), the Note Gu...

23 Dec 2025 8-K: Other Events

Media Contact:Katie [email protected](908) 541-3785

12 Dec 2025 8-K: Other Events

Bausch + Lomb Announces Refinancing of Outstanding Term B Loans

09 Dec 2025 8-K: Other Events

Media Contact:Katie [email protected](908) 541-3785

24 Nov 2025 8-K: Other Events

LAVAL, QC, November 24, 2025 - Bausch Health Companies Inc. (NYSE: BHC)(TSX: BHC) (the “Company” or “Bausch Health”) today announced the commencement of offers to exchange the Company’s outstanding 4.875% Senior Secured Notes due 2028 (t...

29 Oct 2025 8-K: Results of Operations and Financial Condition

LAVAL, QC, October 29, 2025 – Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ("Bausch Health" or the "Company" or "we" or "our") today announced its third quarter 2025 financial results and other key updates from the quarter.

09 Oct 2025 8-K: Submission of Matters to a Vote of Security Holders

On October 7, 2025, Bausch Health Companies Inc. (the “Company”) held a Special Meeting of Shareholders (the “Special Meeting”). At the Special Meeting, the shareholders of the Company voted on the approval of an ordinary resolution rati...

11 Sep 2025 8-K: Other Events

On September 11, 2025, Bausch Health Companies Inc. (“BHC”) and DURECT Corporation (“DURECT”) issued a joint press release announcing the consummation of the transaction previously disclosed in the Current Report on Form 8-K filed by BHC...

15 Aug 2025 8-K: Termination of a Material Definitive Agreement; Departure/Election of Directors or Officers; Compensation +1 more

LAVAL, QC, August 15, 2025 – Bausch Health Companies Inc. (NYSE: BHC)(TSX: BHC) (“Bausch Health” or the “Company”) today announced that Paulson Capital Inc. and certain affiliates and managed funds have increased their ownership of the C...

30 Jul 2025 8-K: Results of Operations and Financial Condition

LAVAL, QC, July 30, 2025 – Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ("Bausch Health" or the "Company" or "we" or "our") today announced its second quarter 2025 financial results and other key updates from the quarter.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support